What We're Reading: Page 155
Industry reads hand-picked by our editors
Apr 15, 2021
Apr 14, 2021
-
The Washington Post
Why Biden health officials decided to pause J&J's coronavirus vaccine
-
The Wall Street Journal
White House Expands List of Potential FDA Commissioners
-
Reuters
AstraZeneca's drug Tagrisso gets China nod for early lung cancer
-
FiercePharma
Alnyam under federal investigation for Onpattro marketing
Apr 13, 2021
-
Business Insider
GlaxoSmithKline stumbled with COVID-19 shots. Now it's facing an exodus of US talent and an uncertain future as the world's vaccine leader.
-
FiercePharma
With crucial EU launch rolling, Amarin's Thero hands CEO baton to new European commercial chief
-
Evaluate Vantage
Quiet times return for biopharma takeouts
-
Endpoints News
Bain doubles down on Tony Coles' quest to get a late-stage Parkinson’s drug through to market
Apr 12, 2021
Apr 09, 2021
-
The New York Times
Kati Kariko Helped Shield the World From the Coronavirus
-
The Boston Globe
MIT scientists launch Future Founders Initiative to help solve biotech’s ‘missing women’ problem
-
Biocentury
CBO report supports biopharma view of value of M&A
-
Barron's
How a Simple Blood Test Could Reduce Cancer Deaths
Apr 08, 2021
-
POLITICO
Senior Trump and Biden officials knew for months about problems at vaccine plant
-
Chemical & Engineering News
Pfizer unveils its oral SARS-CoV-2 inhibitor
-
The Wall Street Journal
Startup Behind AstraZeneca Covid-19 Vaccine Plans to File Publicly for U.S. IPO Within Days
-
Fierce Biotech
Ventus raises $100M to pursue NRLP3, crack undruggable targets
Apr 07, 2021
-
The New York Times
U.S. Bet Big on Covid Vaccine Manufacturer Even as Problems Mounted
-
STAT
Troubling podcast puts JAMA, the ‘voice of medicine,’ under fire for its mishandling of race
-
Vanity Fair
“We Are Hoarding”: Why the U.S. Still Can’t Donate COVID-19 Vaccines to Countries in Need
-
Evaluate Vantage
Biotech venture financing starts the year with a bang
Previous
